VPIM
ACAD icon

Vanguard Personalized Indexing Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
12,265
+4,453
+57% +$106K ﹤0.01% 1660
2025
Q4 		$209K Buy
+7,812
New +$187K ﹤0.01% 1705
2025
Q2 		– Sell
-11,122
Closed -$185K – 1947
2025
Q1 		$185K Sell
11,122
-524
-4% -$9.52K ﹤0.01% 1534
2024
Q4 		$214K Buy
+11,646
New +$188K ﹤0.01% 1500

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return